Announce Date | 01/31/2025 |
EPS Normalized Actual | $2.06 (Miss by $-0.36) |
EPS GAAP Actual | $2.06 (Miss by $-0.36) |
Revenue Actual | $52.226B |
Revenue Surprise | Beat by $52226M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 14.1584 | 10.85 | 12.38736 | 15.7402 | 1 |
Dec 2028 | 13.2 | 11.64 | 8.49196 | 14.80577 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.85 | 1.85 | 52.226B | 9.66% | 52226M |
FQ3 2024 (Sep 2024) | 2.5 | 2.5 | 54.172B | 100% | 54172M |
FQ2 2024 (Jun 2024) | 2.43 | 2.43 | 51.181B | 100% | 51181M |
FQ1 2024 (Mar 2024) | 0.003 | 0.003 | 48.716B | 100% | 48716M |
FQ4 2023 (Dec 2023) | 1.2135 | 1.2135 | 47.18B | -15.56% | 47180M |
FQ4 2022 (Dec 2022) | 3.34 | 3.34 | 54.523B | 100% | 54523M |
FQ1 2022 (Mar 2022) | 3.23 | 3.23 | 52.314B | 100% | 52314M |
FQ2 2022 (Jun 2022) | 5.97 | 5.97 | 65.372B | 100% | 65372M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 4.252 | -- | 3.88164 | 4.54832 | 8 |
FQ3 2027 (Jul 2027) | 4.2736 | -- | 3.90136 | 4.57142 | 5 |
FQ2 2027 (Jun 2027) | 4.2736 | -- | 4.05006 | 4.42521 | 4 |
FQ1 2027 (Mar 2027) | 4.053 | -- | 3.841 | 4.19678 | 4 |
FQ4 2026 (Oct 2026) | 3.68152 | -- | 3.44267 | 3.91671 | 1 |
FQ3 2026 (Jul 2026) | 3.64185 | -- | 3.40558 | 3.8745 | 1 |
FQ2 2026 (Jun 2026) | 3.67416 | -- | 3.24368 | 4.03633 | 3 |
FQ1 2026 (Mar 2026) | 3.63665 | -- | 3.21056 | 3.99513 | 6 |
FQ4 2025 (Oct 2025) | 3.80428 | 51.37 | 3.55747 | 4.04731 | 2 |
FQ3 2025 (Sep 2025) | 3.86069 | 35.24 | 3.40835 | 4.24125 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 81.3B | -- | 75.85B | 85.65B | 3 |
FQ3 2027 (Jul 2027) | 78.12B | -- | 72.89B | 82.31B | 3 |
FQ2 2027 (Jun 2027) | 79.9B | -- | 76.69B | 82.08B | 3 |
FQ1 2027 (Mar 2027) | 76.79B | -- | 73.7B | 78.88B | 3 |
FQ4 2026 (Oct 2026) | 54.56B | -- | 51.84B | 57.24B | 2 |
FQ3 2026 (Jul 2026) | 54.55B | -- | 51.83B | 57.23B | 2 |
FQ2 2026 (Jun 2026) | 54.8B | -- | 49.86B | 58.95B | 2 |
FQ1 2026 (Mar 2026) | 54.83B | -- | 49.89B | 58.99B | 2 |
FQ4 2025 (Oct 2025) | 53.6B | 2.56 | 50.92B | 56.23B | 1 |
FQ3 2025 (Sep 2025) | 54.09B | -0.16 | 49.21B | 58.19B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.85 | 1.85 | 100% | |
FQ3 2024 (Sep 2024) | 2.5 | 2.5 | 100% | |
FQ2 2024 (Jun 2024) | 2.43 | 2.43 | 100% | |
FQ1 2024 (Mar 2024) | 0.003 | 0.003 | 100% | |
FQ4 2023 (Dec 2023) | 1.2135 | 1.2135 | 100% | |
FQ4 2022 (Dec 2022) | 3.34 | 3.34 | 100% | |
FQ1 2022 (Mar 2022) | 3.23 | 3.23 | 100% | |
FQ2 2022 (Jun 2022) | 5.97 | 5.97 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $52.23B | $52226M | 100% |
FQ3 2024 (Sep 2024) | $0B | $54.17B | $54172M | 100% |
FQ2 2024 (Jun 2024) | $0B | $51.18B | $51181M | 100% |
FQ1 2024 (Mar 2024) | $0B | $48.72B | $48716M | 100% |
FQ4 2023 (Dec 2023) | $0B | $47.18B | $47180M | 100% |
FQ4 2022 (Dec 2022) | $0B | $54.52B | $54523M | 100% |
FQ1 2022 (Mar 2022) | $0B | $52.31B | $52314M | 100% |
FQ2 2022 (Jun 2022) | $0B | $65.37B | $65372M | 100% |